A Giant Silence - An atypical association of sensorineural hearing loss with Giant Cell Arteritis
- PMID: 35880512
- PMCID: PMC9796047
- DOI: 10.1111/1756-185X.14401
A Giant Silence - An atypical association of sensorineural hearing loss with Giant Cell Arteritis
Abstract
Giant cell arteritis (GCA) is a chronic vasculitic disorder predominantly affecting medium to large sized arteries, prevalent in the 50 plus age group. This case illustrates an atypical presentation of this disease in the form of bilateral sensorineural hearing loss (SNHL). Apart from the presence of constitutional and vertiginous symptoms, there were essentially no classical features of GCA. Differentials were broad including infection, malignancy and medication toxicity as well as brain, eye and ear syndromes such as Cogan's syndrome, all of which were eventually excluded. Her diagnosis was ultimately confirmed on positron emission tomography, which highlights the diagnostic importance of this modality. She was managed with corticosteroids then tocilizumab and is making a gradual recovery. Literature review demonstrates that SNHL is more prevalent than previously suggested in GCA, although this does not have widespread recognition. Mechanisms of SNHL in GCA include vascular occlusion, immunological mechanisms including cross reactivity with viral antigens and direct viral infection. SNHL does appear to improve with corticosteroids. This case emphasizes the importance of considering GCA as an important differential in SNHL.
Keywords: clinical aspects; disease etiology and pathogenesis; giant cell arteritis; sensorineural hearing loss; vasculitides.
© 2022 The Authors. International Journal of Rheumatic Diseases published by Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors have no conflicts of interest to declare. All co‐authors have seen and agree with the contents of the manuscript and there is no financial interest to report.
Figures

Similar articles
-
Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab.Intern Med. 2022 Apr 15;61(8):1265-1270. doi: 10.2169/internalmedicine.7674-21. Epub 2021 Oct 5. Intern Med. 2022. PMID: 34615818 Free PMC article.
-
[Hearing loss in giant cell arteritis: A case report].Rev Med Interne. 2023 Jan;44(1):31-34. doi: 10.1016/j.revmed.2022.05.008. Epub 2022 Jun 22. Rev Med Interne. 2023. PMID: 35752483 French.
-
Giant Cell Arteritis (GCA): Pathogenesis, Clinical Aspects and Treatment Approaches.Curr Rheumatol Rev. 2019;15(4):259-268. doi: 10.2174/1573397115666190227194014. Curr Rheumatol Rev. 2019. PMID: 30827250 Review.
-
Giant cell arteritis presenting as depressed mood and headache in an elderly patient.J Clin Rheumatol. 2013 Oct;19(7):405-6. doi: 10.1097/RHU.0b013e3182a701e8. J Clin Rheumatol. 2013. PMID: 24048107
-
Update on giant cell arteritis.Curr Opin Ophthalmol. 2003 Dec;14(6):332-8. doi: 10.1097/00055735-200312000-00003. Curr Opin Ophthalmol. 2003. PMID: 14615636 Review.
Cited by
-
Development of the inner ear and regeneration of hair cells after hearing impairment.Fundam Res. 2023 Nov 21;5(1):203-214. doi: 10.1016/j.fmre.2023.09.005. eCollection 2025 Jan. Fundam Res. 2023. PMID: 40166090 Free PMC article. Review.
References
-
- Kermani TA, Schäfer VS, Crowson CS, et al. Increase in age at onset of giant cell arteritis: a population‐based study. Ann Rheum Dis. 2010;69:780‐781. - PubMed
-
- Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B. Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities. Nat Rev Rheumatol. 2017;13(10):578‐592. - PubMed
-
- Calamia KT, Hunder GG. Clinical manifestations of giant cell (temporal) arteritis. Clin Rheum Dis. 1980;6:389‐403.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical